Arkadios Wealth Advisors Sells 2,245 Shares of Exponent, Inc. (NASDAQ:EXPO)

Arkadios Wealth Advisors lessened its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 9.7% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 20,962 shares of the business services provider’s stock after selling 2,245 shares during the period. Arkadios Wealth Advisors’ holdings in Exponent were worth $1,868,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also modified their holdings of EXPO. Kayne Anderson Rudnick Investment Management LLC lifted its position in shares of Exponent by 6.5% during the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock worth $441,414,000 after buying an additional 284,179 shares during the period. JPMorgan Chase & Co. lifted its position in shares of Exponent by 63.6% during the 3rd quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock worth $72,701,000 after buying an additional 245,086 shares during the period. International Assets Investment Management LLC bought a new position in shares of Exponent during the 3rd quarter worth approximately $11,261,000. Geode Capital Management LLC increased its holdings in Exponent by 4.8% during the 3rd quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after purchasing an additional 69,099 shares in the last quarter. Finally, Barclays PLC increased its holdings in Exponent by 219.0% during the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after purchasing an additional 66,263 shares in the last quarter. Institutional investors own 92.37% of the company’s stock.

Insider Activity at Exponent

In other news, Director Paul R. Johnston sold 14,000 shares of Exponent stock in a transaction on Wednesday, November 6th. The stock was sold at an average price of $104.60, for a total value of $1,464,400.00. Following the completion of the sale, the director now directly owns 80,742 shares of the company’s stock, valued at approximately $8,445,613.20. This trade represents a 14.78 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Carol Lindstrom sold 1,039 shares of Exponent stock in a transaction on Monday, November 4th. The shares were sold at an average price of $96.32, for a total value of $100,076.48. Following the completion of the sale, the director now directly owns 5,871 shares of the company’s stock, valued at $565,494.72. This trade represents a 15.04 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,339 shares of company stock valued at $3,103,065 in the last three months. Corporate insiders own 2.10% of the company’s stock.

Exponent Price Performance

EXPO stock opened at $92.34 on Friday. The business has a fifty day moving average price of $93.98 and a 200 day moving average price of $101.49. Exponent, Inc. has a fifty-two week low of $68.70 and a fifty-two week high of $115.75. The stock has a market capitalization of $4.69 billion, a price-to-earnings ratio of 44.61 and a beta of 0.71.

Exponent Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, December 20th. Investors of record on Friday, December 6th were issued a dividend of $0.28 per share. The ex-dividend date of this dividend was Friday, December 6th. This represents a $1.12 dividend on an annualized basis and a yield of 1.21%. Exponent’s dividend payout ratio is 54.11%.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.